FDA Approves Prevacid 24HR for OTC Market

Novartis here announced last week it won over-the-counter approval from the U.S. Food and Drug Administration for Proton Pump Inhibitor Prevacid 24HR (lansoprazole delayed-release capsules 15 mg).

BASEL, Switzerland — Novartis here announced last week it won over-the-counter approval from the U.S. Food and Drug Administration for Proton Pump Inhibitor Prevacid 24HR (lansoprazole delayed-release capsules 15 mg).

This is the first OTC PPI treatment of frequent heartburn since 2003, the company said in a statement.

Prescription-strength Prevacid 24HR treats frequent heartburn for a full 24 hours. Used once daily, Prevacid 24HR works by stopping the release of acid i

Register to view the full article

test - Advanced Registered User

Already a member? .